Mar 11, 2019 Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head Learn moreEn savoir plus
Dec 10, 2018 Connecting patients with specialists in rural and remote communities Learn moreEn savoir plus